PURE Bioscience, Inc. PURE
OTC PK
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 569.00K | 983.00K | 198.00K | 434.00K | 334.00K |
| Total Receivables | 334.00K | 242.00K | 252.00K | 389.00K | 474.00K |
| Inventory | 193.00K | 232.00K | 244.00K | 237.00K | 141.00K |
| Prepaid Expenses | 14.00K | 17.00K | 10.00K | 41.00K | 23.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 75.00K | 75.00K | 75.00K | 75.00K | 75.00K |
| Total Current Assets | 1.19M | 1.55M | 779.00K | 1.18M | 1.05M |
|
|
|||||
| Total Current Assets | 1.19M | 1.55M | 779.00K | 1.18M | 1.05M |
| Net Property, Plant & Equipment | 8.00K | 9.00K | 9.00K | 10.00K | 11.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1.19M | 1.56M | 788.00K | 1.19M | 1.06M |
|
|
|||||
| Total Accounts Payable | 820.00K | 719.00K | 767.00K | 879.00K | 784.00K |
| Total Accrued Expenses | 170.00K | 181.00K | 149.00K | 176.00K | 154.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.38M | 2.75M | 2.14M | 2.10M | 1.18M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 4.37M | 3.65M | 3.06M | 3.16M | 2.11M |
|
|
|||||
| Total Current Liabilities | 4.37M | 3.65M | 3.06M | 3.16M | 2.11M |
| Long-Term Debt | 3.22M | 3.74M | 4.01M | 3.57M | 4.06M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 7.59M | 7.40M | 7.06M | 6.73M | 6.17M |
|
|
|||||
| Common Stock & APIC | 135.08M | 135.03M | 133.97M | 133.91M | 133.88M |
| Retained Earnings | -141.48M | -140.87M | -140.24M | -139.46M | -138.99M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -6.40M | -5.84M | -6.27M | -5.55M | -5.12M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -6.40M | -5.84M | -6.27M | -5.55M | -5.12M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -6.40M | -5.84M | -6.27M | -5.55M | -5.12M |
|
|
|||||